Can fluvoxamine prevent COVID-19 related hospitalization?
Evidence Based Medicine presented by InpharmD™ · InpharmD™
November 10, 20215m 54s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
A randomized, adaptive, platform trial conducted to assess the efficacy of fluvoxamine versus placebo in preventing hospitalization (defined as either retention in a COVID-19 emergency setting or transfer to a tertiary hospital due to COVID-19).